Brief: Iroquois Capital Management Nominated Slate Of 7 Director Candidates For Election To Pharmacyte Biotech Board At Co's 2022 Annual Meeting
23/06/2022 14:26
June 23 (Reuters) -
* IROQUOIS CAPITAL MANAGEMENT, LLC - NOMINATED SLATE OF 7
DIRECTOR
CANDIDATES FOR ELECTION TO PHARMACYTE BIOTECH BOARD AT CO'S 2022
ANNUAL MEETING
* IROQUOIS CAPITAL MANAGEMENT, LLC - DELIVERED A LETTER TO
PHARMACYTE BIOTECH STOCKHOLDERS
Source text for Eikon: ID:nPn8gbQMYa
Further company coverage: PMCB.O
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer